Peptide Decoding
New?New to peptides?Start here →
Decoding

CT-388_Dosage, benefits & legal status

Published July 22, 2026 · Updated August 14, 2026

An experimental weekly weight-loss shot in the tirzepatide family.

Weight lossGLP-1 / GIP agonistInvestigational
Dose4 up to 24 mg per week (trial doses)
FrequencyWeekly
RouteUnder the skin (subcutaneous)
StatusInvestigational
CycledNot cycled in the trials

Common vial size is what vendors typically sell, not a recommendation. Enter your own vial in the calculator.

See how this dose compares across the library →

01

What is CT-388?

Plain language first. The technical label stays, but it never stands alone.

Overview

It works on two appetite-and-blood-sugar signals for weight loss. It is a weekly shot still in trials.

The technical version

CT-388 is a dual GLP-1 and GIP agonist, the same two-receptor family as tirzepatide.

What it's used for

An experimental weekly weight-loss shot in the same family as tirzepatide. It is in testing.

02

How does CT-388 work?

What it does in the body, and where.

CT-388 targets GLP-1 and GIP, the same pair as tirzepatide, with a different molecule.

  1. 01
    Both receptors, once a week
    Appetite and blood-sugar signaling through two gut hormones at once.
  2. 02
    Phase 2 numbers were strong
    The topline result at the highest dose was among the larger figures reported in this class.
  3. 03
    Investigational, and reported mainly by press release
    Peer-reviewed publication is thinner than for the approved drugs, so treat the figures as provisional.
Anatomical illustration highlighting metabolic organs
WHAT THIS COMPOUND ACTS ON:
GLP-1Fullness, slower stomachGIPInsulin after meals
03

What else is it used for?

Each use below carries its own evidence level. Approved means regulators have cleared it for that purpose. Investigational means it is in trials. Early research means it is being studied and is not established.

  • Weight lossInvestigational
  • Type 2 diabetesInvestigational

The published record

Research index

11

Papers and trials about CT-388

Searched: CT-388.

11 papers tagged human · 1 not reviews or lab · 1 clinical trial publications

9 registered trials · none with posted results

Furthest stage reached: Phase 3, under way

Compare this against the whole library →

In animals1
In the lab0
Reviews1
Senior author shareSpread across many groups

Evidence summary

Counted from Europe PMC indexing, not read by a person; a human tag can land on reviews, commentary or lab papers; clinical trial publications is the narrower count.

CT-388 vial rendering
Compound field notes

At a glance

Four things to know about CT-388

01

Evidence

Investigational

02

Category

Weight loss and metabolic

03

Common vial

Varies

04

Half-life

About 6 days

04

How much, and do you cycle it?

The range, and whether you take breaks.

4 up to 24 mg per week (trial doses), weekly. Not cycled in the trials Trial dose

Given continuously for the whole study period: 48 weeks. The dose is stepped up at the start, which is a ramp rather than a cycle, and no trial in this class built in a planned break.

Compare this against the whole library →

05

How long does it stay in the body?

The half-life, and where the figure comes from.

About 6 daysTrial protocol

Source: Phase 1 NCT04838405. PMC12771327, 2025

You can compare this against the whole library to see where it sits.

06

How do I dose and price it?

Enter your vial and your dose. Pick a mix. We show the draw and the cost.

The vial holds a fixed amount of drug. Adding more water does not make more drug, it just spreads it thinner, so you draw a bigger number on the syringe for the same dose.

Your vial size (mg)
Enter the amount printed on your label.
What you paid per vial
$
Used for cost per dose only.
Your dose (mg)
Commonly referenced range: 4 up to 24 mgTrial dose

Choose your mix

your own mL
units · —
Enter your own volume

Measuring the water1 mL = one full 100-unit syringe.

YOUR DRAW0 / 100 units
07

How do you store it?

Before mixing, and after.

Nothing to store: it is not sold anywhere.

CT-388 has never been marketed, so there is no vial, pen or bottle to keep at home. Supplies for a trial are made, stored and dispensed by the sponsor and the trial pharmacy under conditions set in the protocol. Anything offered for sale under this name did not come from that supply chain.

08

What are the side effects and cautions?

Known cautions and warnings for this compound.
Handling note

This compound is in clinical trials and is not sold in a standard vial, so there is no common vial size to show. Trial doses are given as prepared by the study, and the reconstitution calculator does not apply. Doses up to 24 mg a week are more than twice the 10 mg reference vial.

Who should avoid it

Check these before anything else.
  • No formal contraindications established
  • Pregnancy

Stop and get help

These are emergencies. Seek care.
  • Vomiting badly enough that you cannot keep fluids down
  • Severe stomach pain that spreads to your back
  • Signs of an allergic reaction such as face or throat swelling, hives, or trouble breathing

Common effects

Expected, and usually mild.
  • Mild to moderate stomach effects, consistent with this drug family
  • In Phase 2, about 6% stopped because of side effects against 1% on placebo

Where this page says nothing is established, that means nobody has studied it, not that a compound is safe.

09

Is CT-388 approved?

And where the numbers on this page come from.

No. CT-388 is not approved anywhere and is currently in company-run clinical trials. There is no legal route to obtain it outside a trial.

  • Approval status
    Investigational
  • Route
    Under the skin (subcutaneous)
  • Checked
    14 August 2026
  • Dose
    From published clinical trials. Not approved by a regulator for this dose.
  • Vial size
    From what vendors typically list; not a recommendation.
  • Sources
    None traced yet.

What has happened recently

We have not yet written a full regulatory note for this compound. The status above is current as of the date shown.

Guides for this compound

Sources

No primary source has been traced for this compound yet. Treat everything on this page as unverified until one is. How we grade evidence

Beyond these, 11 records are indexed. Browse the records